Literature DB >> 15663935

Target-site preferences of Sleeping Beauty transposons.

Geyi Liu1, Aron M Geurts, Kojiro Yae, A R Srinivasan, Scott C Fahrenkrug, David A Largaespada, Junji Takeda, Kyoji Horie, Wilma K Olson, Perry B Hackett.   

Abstract

The Sleeping Beauty (SB) transposon is a Tc1/mariner family transposon that has applications in vertebrate animals for gene transfer, gene-tagging, and human gene therapy. In this study, we analyzed the target-site preferences of the SB transposon. At the genomic level, integration of SB transposons with respect to genes (exons and introns) and intergenic regions appears fairly random but not on a micro-scale. Although there appears to be a consensus sequence around the vicinity of the target sites, the primary sequence is not the determining factor for target selection. When integrations were examined over a limited topography, the sites used most often for integration did not match the consensus sequence. Rather, a unique deformation inherent in the sequence may be a recognition signal for target selection. The deformation is characterized by an angling of the target site such that the axis around the insertion site is off-center, the rotation of the helix (twisting) is non-uniform and there is an increase in the distance between the central base-pairs. Our observations offer several hypothetical insights into the transposition process. Our observations suggest that particular deformations of the double helix predicted by the V(step) algorithm can distinguish TA sites that vary by about 16-fold in their preferences for accommodating insertions of SB transposons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663935     DOI: 10.1016/j.jmb.2004.09.086

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  67 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Retargeting sleeping beauty transposon insertions by engineered zinc finger DNA-binding domains.

Authors:  Katrin Voigt; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2012-07-10       Impact factor: 11.454

3.  Endogenous transposases affect differently Sleeping Beauty and Frog Prince transposons in fish cells.

Authors:  Jose Braulio Gallardo-Gálvez; Teresa Méndez; Julia Béjar; M Carmen Alvarez
Journal:  Mar Biotechnol (NY)       Date:  2010-12-01       Impact factor: 3.619

4.  Establishment of a pig fibroblast-derived cell line for locus-directed transgene expression in cell cultures and blastocysts.

Authors:  Jannik E Jakobsen; Juan Li; Brian Moldt; Peter M Kragh; Henrik Callesen; Jens Michael Hertz; Lars Bolund; Arne Lund Jørgensen; Jacob Giehm Mikkelsen; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2010-03-25       Impact factor: 2.316

5.  High-resolution genome-wide mapping of transposon integration in mammals.

Authors:  Stephen R Yant; Xiaolin Wu; Yong Huang; Brian Garrison; Shawn M Burgess; Mark A Kay
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 6.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

7.  Target site selection of Pseudomonas putida transposon Tn4652.

Authors:  Paula Ann Kivistik; Maia Kivisaar; Rita Hõrak
Journal:  J Bacteriol       Date:  2007-03-09       Impact factor: 3.490

Review 8.  Transposon tools hopping in vertebrates.

Authors:  Jun Ni; Karl J Clark; Scott C Fahrenkrug; Stephen C Ekker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-11

Review 9.  Targeted gene insertion for molecular medicine.

Authors:  Katrin Voigt; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  J Mol Med (Berl)       Date:  2008-07-08       Impact factor: 4.599

10.  Transposon-mediated mutagenesis of somatic cells in the mouse for cancer gene identification.

Authors:  David A Largaespada
Journal:  Methods       Date:  2009-07-14       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.